Search for: "ASTRAZENECA LP" Results 61 - 80 of 161
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2012, 5:00 am
District Judge Colleen Kollar-Kotelly for the District of Columbia dismissed without prejudice AstraZeneca Pharmaceuticals LP's ("AstraZeneca's") suit against FDA requesting declaratory and injunctive relief to prevent FDA from granting final approval to generic versions of Seroquel® (quetiapine fumarate) or Seroquel XR® (extended-release quetiapine fumarate). [read post]
26 Mar 2012, 1:43 am by FDABlog HPM
District Court for the District of Columbia denied AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) Application for Prelimiary Injunction and dismissed without prejudice the action AstraZeneca filed on March 12, 2012 seeking to enjoing FDA from granting final ANDA approval for a generic version of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets (NDA No. 020639) as early as March 26, 2012 (as well… [read post]
25 Mar 2012, 9:25 pm by Patent Docs
Mylan Laboratories Ltd, et al. 3:12-cv-01378; filed March 6, 2012 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI... [read post]
24 Mar 2012, 1:20 pm by Stewart Walsh
AstraZeneca Pharmaceuticals LP to surprise, and unpleasantly upend the patentee. [read post]
15 Mar 2012, 5:00 am
Malkin On March 12, AstraZeneca Pharmaceuticals LP ("AstraZeneca") sued FDA in the District Court for the District of Columbia requesting declaratory and injunctive relief to prevent FDA from granting final approval to generic versions of Seroquel® (quetiapine fumarate) or Seroquel XR® (extended-release quetiapine fumarate). [read post]
27 Feb 2012, 3:30 am
AstraZeneca Pharmaceuticals, LP, No. 1:10CV104-SA-JAD, 2010 WL 3951906 (N.D. [read post]
23 Feb 2012, 6:22 am by Asher Bearman
In contrast, corporate VC operations are built on a variety of structures, some of which are quite simple, and some of which resemble the traditional GP/LP structure, but many of which are novel and innovative. [read post]
29 Dec 2011, 6:53 am by Bexis
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011). [read post]
15 Dec 2011, 10:17 am by Bexis
AstraZeneca Pharmaceuticals LP, No. 3:11-cv-04001-JAP-TJB, slip op. [read post]
11 Dec 2011, 9:00 pm by Stephanie Figueroa
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]
11 Dec 2011, 9:00 pm by Stephanie Figueroa
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]